BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1100970)

  • 1. Low dose dapsone therapy in lepromatous leprosy.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
    [No Abstract]   [Full Text] [Related]  

  • 2. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 5. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1972 Jul; 21(4):440-5. PubMed ID: 4559065
    [No Abstract]   [Full Text] [Related]  

  • 6. The continuous bacteremia of lepromatous leprosy.
    Drutz DJ; Chen TS; Lu WH
    N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
    [No Abstract]   [Full Text] [Related]  

  • 7. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 9. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings.
    McDougall AC; Weddell AG; Rees RJ
    Lepr Rev; 1975 Dec; 46(4):267-77. PubMed ID: 1107726
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 11. A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1015-8. PubMed ID: 362951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
    Waters MF; Rees RJ; McDougall AC; Weddell AG
    Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
    [No Abstract]   [Full Text] [Related]  

  • 13. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings.
    Barton RP; Hogerzeil LM
    Lepr Rev; 1975 Dec; 46(4):257-65. PubMed ID: 1107725
    [No Abstract]   [Full Text] [Related]  

  • 14. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 16. The number of Mycobacterium leprae in the pretreatment biopsy-specimen does not determine the rate of response of patients with lepromatous leprosy to chemotherapy with acedapsone.
    Levy L; Shepard CC
    Lepr Rev; 1986 Mar; 57(1):27-31. PubMed ID: 3517535
    [No Abstract]   [Full Text] [Related]  

  • 17. Viability of blood-borne Mycobacterium leprae.
    Drutz DJ; O'Neill SM; Levy L
    J Infect Dis; 1974 Sep; 130(3):288-92. PubMed ID: 4607341
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone-resistant leprosy in Burundi.
    Bourland J; Van Loo L; Pattyn SR
    Lepr Rev; 1983 Sep; 54(3):239-42. PubMed ID: 6355726
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.